Page 1 of 3 Press Release 17TC09 Current April 2009 Telsonic Increases its Activities in Sonochemistry Field Crystallisation in Focus (Bronschhofen) Switzerland based Telsonic AG is increasing its activities in the Sonochemistry field. The ultrasonics specialist has entered into a strategic partnership with Prodema Medical. They mean to use innovative products to introduce their skills effectively into chemical, pharmaceutical and foodstuffs technology. For instance, a crystallisation process accelerated with ultrasonics can produce medication of the highest degree of purity and the newest generation of equipment can be used in the laboratory as well as in series production. "Our products for ultrasonic process technology can be used in laboratory applications as well as for series production of the purest active ingredients", said Area Sales Manager Dr Holger Keller, emphasising one characteristic of Telsonic products for chemical and biological process technology. "We want to position this skill much more vigorously in the market", added Telsonic Sales Director Ernst Züblin. For this reason the Swiss ultrasonics specialist has entered into a strategic partnership with Prodema Medical. The management and engineering company, also based in Switzerland, has the best knowledge of and contacts to the chemical and pharmaceutical sector. "Based on many years of work we know the processes as well as the important contacts in industry and research", emphasised Professor Christian Spenger. "Using the effective Telsonic products we'll also be expanding our spectrum", added the Prodema manager, emphasising the win-win partnership. Win-win partnership for the customers' benefit The process of crystallisation is used in the pharmaceutical industry for cleaning reaction products. Size and purity of the crystal are decisive quality characteristics and key to the optimal absorption, dispersion and effect of medication in the body. The development and purity of active pharmaceutical ingredient crystals can be positively influenced by means of ultrasonics. To do this the medication is first produced in the smallest possible Contact and information: TELSONIC AG Dr. Holger Keller Industriestrasse 6b CH-9552 Bronschhofen Headquarters Tel +41 71 913 98 88 Fax +41 71 913 98 77 [email protected] www.telsonic.com Telsonic in Germany TELSONIC GmbH Munich Office Christian Horn Waldstraße 26 D-82041 Oberbiberg Tel.: +49 89 6666 55 39 Fax: +49 3112 1149 772 [email protected] www.telsonic.de
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1 of 3
Press Release 17TC09 Current April 2009
Telsonic Increases its Activities in Sonochemistry Field
Crystallisation in Focus (Bronschhofen) Switzerland based Telsonic AG is increasing its activities in the Sonochemistry field. The ultrasonics specialist has entered into a strategic partnership with Prodema Medical. They mean to use innovative products to introduce their skills effectively into chemical, pharmaceutical and foodstuffs technology. For instance, a crystallisation process accelerated with ultrasonics can produce medication of the highest degree of purity and the newest generation of equipment can be used in the laboratory as well as in series production.
"Our products for ultrasonic process technology can be used in laboratory applications as well as for series production of the purest active ingredients", said Area Sales Manager Dr Holger Keller, emphasising one characteristic of Telsonic products for chemical and biological process technology. "We want to position this skill much more vigorously in the market", added Telsonic Sales Director Ernst Züblin. For this reason the Swiss ultrasonics specialist has entered into a strategic partnership with Prodema Medical. The management and engineering company, also based in Switzerland, has the best knowledge of and contacts to the chemical and pharmaceutical sector. "Based on many years of work we know the processes as well as the important contacts in industry and research", emphasised Professor Christian Spenger. "Using the effective Telsonic products we'll also be expanding our spectrum", added the Prodema manager, emphasising the win-win partnership.
Win-win partnership for the customers' benefit
The process of crystallisation is used in the pharmaceutical industry for cleaning reaction products. Size and purity of the crystal are decisive quality characteristics and key to the optimal absorption, dispersion and effect of medication in the body. The development and purity of active pharmaceutical ingredient crystals can be positively influenced by means of ultrasonics. To do this the medication is first produced in the smallest possible
Contact and information:
TELSONIC AG Dr. Holger Keller Industriestrasse 6b CH-9552 Bronschhofen Headquarters Tel +41 71 913 98 88 Fax +41 71 913 98 77 [email protected] www.telsonic.com
Telsonic in Germany TELSONIC GmbH Munich Office Christian Horn Waldstraße 26 D-82041 Oberbiberg Tel.: +49 89 6666 55 39 Fax: +49 3112 1149 772 [email protected] www.telsonic.de
Page 2 of 3
quantity. When the effect is demonstrable, the manufacturing is scaled up, in ever increasing volumes, to a production scale. In the Desintegrator DG 100 and the Sonoprocessor DG2000 Telsonic provides an equipment series that is geared towards scaleability.
A special mini reactor, equivalent to a series product reactor, has been developed for use in the laboratory. In production the components can be used either in batches or in a continuous flow procedure. By controlling the ultrasonics effect with the selection of probe geometry and the energy applied, the required effect - locally focussed or permeating the whole volume - is optimally tuned to the process step. On request, customers can take delivery of components complete with ATEX certification, suitable for use in explosion proof areas of the chemical-pharmaceutical industry.
Swiss pioneer and technology leader
The Swiss Telsonic AG is the pioneer in the field of ultrasonic technology. The company, founded in 1966, with subsidiaries in Germany, England, South-East Europe, China and the USA as well as a joint venture in India and representatives in many other countries, holds numerous patents. It applies ultrasonic technology to welding, separation welding, cleaning and sieving, as well as to chemical processes. Prodema Medical is an ambitious Swiss company that has wealth of knowledge pertinent to the pharmaceutical and chemical processes and can draw on a tight network of relationships in industry and research.
Page 3 of 3
Image Nr. 17-01 TC_.jpg
Image Nr. 17-02 TC_.jpg
Related Documents
